As new research shines a light on the staggering rise in cardiovascular disease (CVD) across Asia, it has never been clearer that urgent action is needed to address this growing public health crisis.
A 2024 study published in The Lancet titled The Burden of Cardiovascular Disease in Asia from 2025 to 2050 forecasts that by 2050, the incidence of cardiovascular events will have surged by an alarming 91.2% across the region.1 Australia is projected to face $141 billion in CVD-related costs by 20292. These figures underscore the need for renewed focus on preventative strategies, including the often-overlooked role of assessing mitochondrial health as part of the overall picture of cardiovascular function.
In line with this year’s World Heart Day theme, Use Heart for Action, we are encouraging everyone to take deliberate steps towards improving heart health, both at an individual and systemic level. Action means moving beyond awareness and into the tangible, impactful efforts required to change policy, encourage behaviour shifts towards heart-healthy living, and integrating mitochondrial health into broader cardiovascular care and assessment strategies.
The heart is one of the most energy-demanding organs in the body, with over 95% of its energy —measured in adenosine triphosphate (ATP) —produced by mitochondria. Heart muscle function and contractility require the ATP produced by mitochondria for fuel, and this process is supported by the antioxidant Ubiquinol.
This World Heart Day, health experts are calling for a shift in perspective when it comes to understanding CVD rise, advocating instead for healthcare practitioners to include mitochondrial function in their routine cardiovascular health evaluations. With younger age groups now presenting with cardiovascular conditions, it has underscored the need for early detection of mitochondrial dysfunction.
One of the most promising ways to maintain healthy heart and mitochondrial function is through achieving optimal levels of Ubiquinol. Supported by 100+ scientific studies, Ubiquinol is now considered to be a central strategy in supporting cardiovascular health.
“Scientific evidence of more than 100 studies clearly shows the correlation between the depletion of endogenous Ubiquinol levels and heart conditions impacting endothelial function, healthy cholesterol and mitochondrial function” — Australia’s leading Integrative Cardiologist, Dr Ross Walker.
A healthy heart translates to a healthier life, which is why we are heeding the call to consult a healthcare practitioner for a cardiovascular check-up this World Heart Day. Let’s strive to find the balance between a nutrient-rich diet, optimal Ubiquinol levels, adequate sleep, reduced stress, and increased social connection for a healthy heart for life.
References:
Goh RSJ, et al. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. The Lancet Regional Health – Western Pacific 2024(49): 101138.
Vision 2050. Heart Foundation 2024. Viewed 24 September 2024, https://www.heartfoundation.org.au/vision2050
Always read the label and follow the directions for use. Consult your healthcare professional to establish if Ubiquinol is suitable for your needs.
How Kaneka Ubiquinol™ can Mitigate the Effects of Stress and Poor Sleep The events that…
In an outstanding achievement, Kaneka Ubiquinol™, the global supplier of bioidentical Ubiquinol, has been awarded the Raw…
Kaneka Ubiquinol at the Complementary Medicines Australia Conference 2024 Today, Kaneka Ubiquinol was proud to…
Webinar with Dr Ross Walker, Integrative Cardiologist Our recent webinar, A Pharmacist’s Guide to Ubiquinol’s…
Kaneka Ubiquinol™ in New Zealand for Industry Innovation The Kaneka team was proud to attend…
How Ubiquinol Can Assist Startling Global Decline in Fertility Rates Male fertility rates have declined sharply…